Andrew South to Angiotensin II Type 1 Receptor Blockers
This is a "connection" page, showing publications Andrew South has written about Angiotensin II Type 1 Receptor Blockers.
Connection Strength
0.201
-
Puskarich MA, Ingraham NE, Merck LH, Driver BE, Wacker DA, Black LP, Jones AE, Fletcher CV, South AM, Murray TA, Lewandowski C, Farhat J, Benoit JL, Biros MH, Cherabuddi K, Chipman JG, Schacker TW, Guirgis FW, Voelker HT, Koopmeiners JS, Tignanelli CJ. Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical Trial. JAMA Netw Open. 2022 Mar 01; 5(3):e222735.
Score: 0.201